Brown Brothers Harriman & Co. trimmed its stake in MetLife, Inc. (NYSE:MET – Free Report) by 8.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,141 shares of the financial services provider’s stock after selling 1,006 shares during the period. Brown Brothers Harriman & Co.’s holdings in MetLife were worth $919,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the stock. MeadowBrook Investment Advisors LLC grew its holdings in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its stake in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares during the last quarter. Wolff Wiese Magana LLC increased its holdings in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new position in shares of MetLife in the third quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC boosted its holdings in shares of MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors and hedge funds.
MetLife Stock Performance
Shares of MetLife stock opened at $87.77 on Wednesday. The firm has a fifty day moving average of $82.87 and a two-hundred day moving average of $76.29. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market capitalization of $60.77 billion, a price-to-earnings ratio of 17.70, a PEG ratio of 0.79 and a beta of 1.05. MetLife, Inc. has a 52 week low of $62.81 and a 52 week high of $87.88.
MetLife Announces Dividend
Wall Street Analyst Weigh In
MET has been the subject of a number of recent analyst reports. Jefferies Financial Group raised their price target on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. Barclays decreased their price objective on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Monday. TD Cowen began coverage on shares of MetLife in a research note on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target on the stock. Finally, Wells Fargo & Company boosted their price objective on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $88.46.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- What is a Death Cross in Stocks?
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- The Risks of Owning Bonds
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What Are Dividends? Buy the Best Dividend Stocks
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.